| JOHNSON & JOHNSON (J&J) |
| USA |
| Gesundheit |
| US4781601046 / 853260 |
| JNJ (Frankfurt) / JNJ (NYSE) |
| FRA:JNJ, ETR:JNJ, JNJ:GR, NYSE:JNJ |
| https://www.jnj.com/ |
|
Johnson & Johnson is a holding company engaged in the research, development, manufacture, and sale of healthcare products worldwide. It operates through two primary segments: Innovative Medicine, which focuses on pharmaceuticals including treatments ..
>Volltext.. |
| 479263.13 Mio. EUR |
| 507736.34 Mio. EUR |
| 84002.46 Mio. EUR |
| 29324.98 Mio. EUR |
| 18341.19 Mio. EUR |
| 7.62 EUR |
| 47933.78 Mio. EUR |
| 18906.07 Mio. EUR |
| 19936.45 Mio. EUR |
| 0.38 |
| 1.01% |
| -9.67% |
| 4.5 EUR |
| 2.29% |
| 2.35% |
| 26.05.26 - 1.151596€ 24.02.26 - 1.1031799€ >weitere anzeigen... |
| JOHNSON & JOHNSON, J&J, JOHNSON&JOHNSON, JOHNSONJOHNSON, JNJ, JOHNSON AND JOHNSON, JOHNSON JOHNSON |
| 20.06.26 |
|